Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
about
Platinum-induced hearing loss after treatment for childhood cancerIntra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D RetinoblastomaTime-frequency analysis of transient-evoked otoacoustic emissions in children exposed to carboplatin chemotherapyCarboplatin-associated ototoxicity in children with retinoblastoma.Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicityEvaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology GroupOphthalmic artery chemosurgery for less advanced intraocular retinoblastoma: five year review.Treatment with connexin 46 siRNA suppresses the growth of human Y79 retinoblastoma cell xenografts in vivoChemoreduction improves eye retention in patients with retinoblastoma: a report from the German Retinoblastoma Reference Centre.Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor studyAuditory late effects of childhood cancer therapy: a report from the Children's Oncology GroupIncidence of platinum-induced ototoxicity in pediatric patients in Quebec.Retinoblastoma: Recent trends A mini review based on published literature.Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy.Asymmetric and unilateral hearing loss in childrenTargeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors.Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study.Monitoring carboplatin ototoxicity with distortion-product otoacoustic emissions in children with retinoblastomaLow-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.Intra-arterial chemotherapy as a treatment for intraocular retinoblastoma: alternatives to direct ophthalmic artery catheterization.Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.Models and discovery strategies for new therapies of retinoblastoma.Management of retinoblastoma in children: current status.Hypersensitivity to Carboplatin in Children with Malignancy.Lack of vincristine infiltrates in patients with retinoblastoma receiving chemotherapy by peripheral intravenous lines.Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up study.Audiological monitoring in Swiss childhood cancer patients.Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma.Ototoxicity in retinoblastoma survivors treated with carboplatin based chemotherapy: A cross-sectional study of 116 patients.Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.Retinoblastoma
P2860
Q26470526-387A2D56-8A6E-44E4-AA30-21CDCC0B39EDQ28552363-CE133031-6215-4E99-A739-672A4377636DQ30444977-2DC473F9-055F-4068-B9A6-987DC604DBA0Q30513911-1F630ABC-75D1-436D-9FC3-CE4D44D64C81Q33400825-FA91A71E-4957-4C25-8F7A-02A7B0F7869FQ33922193-C54746A3-0228-41BD-A671-C4C2F31FF0D1Q34251018-1FD33B24-EACF-4012-A724-C9FC0087A0CDQ34699375-2562C92E-11DB-484B-AC66-975FAB711E5FQ34829846-09DA9B38-13DA-499B-B3B1-93B99FBBA3B8Q34970231-407EAEF4-FA17-4CD3-84A0-B2B6CA76D633Q35019735-AA194EE3-930F-4612-9A45-A8C5866DE185Q35197338-B1DFBE32-4FB1-4139-AD8E-B8FA7E85010CQ35686255-79BF68A1-7483-4211-B7FB-6B3D2A448857Q35795658-B8D79E97-A325-43E1-8EDD-73CA5973B8A5Q35811983-851F0EE2-13C6-4DAE-9518-252BBF9282AAQ35981061-764385C7-24EE-43D1-9EEC-2988945B2447Q36253772-E54BCD82-2455-4A64-9319-D44A159D45DCQ36676415-71D12E34-76E7-45B6-9F92-038D4D0B5521Q36843442-AF9AC4A6-19E0-428C-84F8-723552A4CD6AQ37914108-E337F101-CAF1-4DD5-9B97-75233F8D1C01Q37996374-F507A530-F4A5-4B5C-8842-E51C41CD2CDEQ38045274-30DBEE0C-70B4-4473-A87B-1B752BD43E9DQ38083299-4820C6E3-22F8-429B-AF25-AF52D544CC67Q38368017-DF55D9DF-4709-4D19-9069-FBA87001D1E8Q38817913-7F324748-DC4E-4C37-9375-F5EE73A0348DQ41269037-8DDC99D7-5AB9-4F84-A60F-E005F769B119Q41465765-6DE8CEC2-36FC-4E55-A034-EA23B2DB2CD8Q47577823-9762DE0F-A095-46C4-908C-9B21B3F8718EQ47647048-235FDF4B-46A0-43CB-B40A-0C55301A0993Q50316767-219DB6DF-40CF-4A53-B507-2C099E275D2CQ50352441-A948124F-A41C-4BED-8928-E7B4D467D991Q52870608-28601785-37D1-4958-B443-5216ACB052BDQ58347703-E5BA48DE-40DC-4011-9D91-3FC3369A3F7D
P2860
Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Analysis of ototoxicity in you ...... l or bilateral retinoblastoma.
@ast
Analysis of ototoxicity in you ...... l or bilateral retinoblastoma.
@en
type
label
Analysis of ototoxicity in you ...... l or bilateral retinoblastoma.
@ast
Analysis of ototoxicity in you ...... l or bilateral retinoblastoma.
@en
prefLabel
Analysis of ototoxicity in you ...... l or bilateral retinoblastoma.
@ast
Analysis of ototoxicity in you ...... l or bilateral retinoblastoma.
@en
P2093
P356
P1476
Analysis of ototoxicity in you ...... l or bilateral retinoblastoma.
@en
P2093
Alexia Savignoni
Danielle Bours
Ghislaine Mercier
Isabelle Aerts
Laurence Desjardins
Mathilde Jehanne
P304
P356
10.1002/PBC.21898
P577
2009-05-01T00:00:00Z